A Novel Calmodulin Antagonist O-(4-Ethoxyl-Butyl)-Berbamine Overcomes Multidrug Resistance in Drug-Resistant MCF-7/ADR Breast Carcinoma Cells
Author:
Publisher
Elsevier BV
Subject
Pharmaceutical Science
Reference39 articles.
1. Multidrug resistance in cancer: Role of ATP-dependent transporters;Gottesman;Nat Rev Cancer,2002
2. Human placental transport of vinblastine, vincristine, digoxin and progesterone: Contribution of P-glyco-protein;Ushigome;Eur J Pharmacol,2000
3. Inhibition of the P-glycoprotein and multidrug resistance protein-mediated efflux of anthracyclines and calceina cetoxymethyl ester by PAK-104P;Marbeuf-Gueye;Eur J Pharmacol,2000
4. The functions and structure of ABC transporters: Implications for the design of new inhibitors of P-glycoprotein and MRP1 to control multidrug resistance (MDR);Teodori;Curr Drug Targets,2006
5. Modulation by flavonoids of cell multidrug resistance mediated by P-glycoprotein and related ABC transporters;Di Pietro;Cell Mol Life Sci,2002
Cited by 26 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Synergistic Anticancer Effect of a Combination of Berbamine and Arcyriaflavin A against Glioblastoma Stem-like Cells;Molecules;2022-11-17
2. Lubeluzole Repositioning as Chemosensitizing Agent on Multidrug-Resistant Human Ovarian A2780/DX3 Cancer Cells;Molecules;2022-11-15
3. Cytotoxicity of synthetic derivatives against breast cancer and multi-drug resistant breast cancer cell lines: a literature-based perspective study;Cancer Cell International;2021-11-20
4. Berbamine Inhibits Cell Proliferation and Migration and Induces Cell Death of Lung Cancer Cells via Regulating c-Maf, PI3K/Akt, and MDM2-P53 Pathways;Evidence-Based Complementary and Alternative Medicine;2021-07-08
5. Proliferation, migration and invasion of triple negative breast cancer cells are suppressed by berbamine via the PI3K/Akt/MDM2/p53 and PI3K/Akt/mTOR signaling pathways;Oncology Letters;2020-11-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3